Bristol Myers Squibb - 51 Year Stock Price History | BMY

Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits and dividends. The latest closing stock price for Bristol Myers Squibb as of September 22, 2023 is 58.90.
  • The all-time high Bristol Myers Squibb stock closing price was 78.44 on December 02, 2022.
  • The Bristol Myers Squibb 52-week high stock price is 81.44, which is 38.3% above the current share price.
  • The Bristol Myers Squibb 52-week low stock price is 58.33, which is 1% below the current share price.
  • The average Bristol Myers Squibb stock price for the last 52 weeks is 68.82.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bristol Myers Squibb Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2023 65.4335 69.8633 72.6291 58.5800 58.9000 -15.33%
2022 69.6464 58.0154 78.4391 58.0154 69.5636 19.00%
2021 58.3647 56.2205 64.4476 50.2806 58.4560 2.89%
2020 54.4994 56.2414 59.8731 41.1999 56.8159 0.39%
2019 43.7040 44.6447 56.5941 37.3994 56.5941 27.86%
2018 48.6911 50.8473 57.5789 41.5197 44.2615 -12.91%
2017 47.2833 47.9968 54.1978 38.0493 50.8224 7.72%
2016 50.5345 53.1471 61.5531 39.7457 47.1814 -13.50%
2015 50.4483 46.1145 55.7601 44.9047 54.5426 19.24%
2014 39.7904 39.3970 47.2075 35.3609 45.7426 14.18%
2013 32.4818 23.9114 40.3073 23.9114 40.0603 69.95%
2012 23.7218 24.3383 25.8841 22.2841 23.5715 -3.78%
2011 19.8066 17.6368 24.5330 16.7784 24.4982 39.43%
2010 16.7219 16.4009 18.3185 14.5313 17.5705 8.74%
2009 13.4552 14.4589 16.4070 10.6020 16.1577 14.78%
2008 12.6454 14.9384 15.4815 10.3109 14.0775 -6.05%
2007 16.0551 14.4892 17.9895 14.3354 14.9836 4.75%
2006 12.8903 12.0627 14.3044 10.8763 14.3044 19.92%
2005 12.3558 12.6162 13.4312 10.9156 11.9278 -6.16%
2004 12.2619 14.0669 14.6852 11.0331 12.7105 -7.27%
2003 11.7964 11.0278 13.7074 9.6969 13.7074 29.02%
2002 13.7594 22.3568 22.5547 9.2066 10.6239 -52.36%
2001 24.8820 30.6783 30.6783 21.4255 22.3000 -29.71%
2000 24.8091 27.1967 31.7252 18.4354 31.7252 17.11%
1999 28.6187 27.1645 32.8944 24.0896 27.0912 -2.80%
1998 22.5161 19.5012 27.8728 18.5079 27.8728 42.93%
1997 15.5472 10.8214 20.0742 10.8214 19.5012 77.07%
1996 9.1287 8.3095 11.6144 7.8751 11.0134 32.15%
1995 6.5898 5.5428 8.3581 5.4610 8.3338 53.27%
1994 5.0874 5.1234 5.6240 4.5748 5.4375 6.09%
1993 5.0492 5.6283 5.6283 4.4428 5.1252 -9.48%
1992 5.9307 7.1816 7.2223 5.1621 5.6618 -21.16%
1991 6.3367 5.2578 7.1816 4.8435 7.1816 35.84%
1990 4.5621 4.3205 5.2985 3.8826 5.2870 24.56%
1989 3.6741 3.2304 4.2897 3.2028 4.2447 28.87%
1988 3.0674 3.1138 3.3118 2.7718 3.2938 9.90%
1987 3.4337 3.0371 3.9597 2.6278 2.9971 0.77%
1986 2.7245 2.3668 3.1631 2.1735 2.9741 24.71%
1985 2.1097 1.8449 2.4341 1.7909 2.3848 26.48%
1984 1.6700 1.5526 1.8899 1.5029 1.8855 23.97%
1983 1.3977 1.2059 1.7146 1.1339 1.5209 25.65%
1982 1.0698 0.9494 1.3184 0.9203 1.2104 26.57%
1981 0.9421 0.9179 1.0529 0.8303 0.9563 5.46%
1980 0.7328 0.6548 0.9248 0.5535 0.9068 36.16%
1979 0.6219 0.6411 0.6884 0.5625 0.6660 3.50%
1978 0.6062 0.6008 0.7154 0.5085 0.6435 6.31%
1977 0.5863 0.6120 0.6411 0.5197 0.6053 -1.99%
1976 0.6580 0.6232 0.7447 0.5568 0.6176 -0.35%
1975 0.5588 0.4600 0.6625 0.4240 0.6198 37.40%
1974 0.4181 0.4207 0.5051 0.2846 0.4511 8.10%
1973 0.5503 0.6165 0.6424 0.3960 0.4173 -32.80%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $123.048B $46.159B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $143.193B 15.06
Gilead Sciences (GILD) United States $93.464B 11.94
Vertex Pharmaceuticals (VRTX) United States $90.212B 26.58
Regeneron Pharmaceuticals (REGN) United States $89.544B 21.61
CSL (CSLLY) Australia $78.633B 0.00
GSK (GSK) United Kingdom $76.638B 10.40
Seagen (SGEN) United States $40.111B 0.00
Moderna (MRNA) United States $38.055B 36.90
Biogen (BIIB) United States $37.318B 15.87
Argenex SE (ARGX) Netherlands $29.610B 0.00
Horizon Therapeutics Public (HZNP) Ireland $26.474B 25.75
BioNTech SE (BNTX) Germany $25.217B 5.87
Genmab (GMAB) Denmark $23.833B 36.08
Alnylam Pharmaceuticals (ALNY) United States $21.444B 0.00
Illumina (ILMN) United States $20.965B 150.50
BeiGene (BGNE) Cayman Islands $18.457B 0.00
BioMarin Pharmaceutical (BMRN) United States $16.279B 86.51
Incyte (INCY) United States $13.020B 31.75
Exact Sciences (EXAS) United States $12.077B 0.00
Bio-Techne Corp (TECH) United States $10.974B 39.13
Bio-Rad Laboratories (BIO.B) United States $10.868B 30.51
Sarepta Therapeutics (SRPT) United States $10.554B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $10.533B 0.00
Legend Biotech (LEGN) United States $10.426B 0.00
QIAGEN (QGEN) Netherlands $8.988B 18.95
Repligen (RGEN) United States $8.952B 61.28
Roivant Sciences (ROIV) United Kingdom $7.972B 0.00
Sino Biopharmaceutical (SBMFF) Hong Kong, SAR China $6.961B 0.00
Exelixis (EXEL) United States $6.839B 42.12
Reata Pharmaceuticals (RETA) United States $6.574B 0.00
Karuna Therapeutics (KRTX) United States $6.254B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $5.888B 19.00
Ascendis Pharma (ASND) Denmark $5.433B 0.00
Halozyme Therapeutics (HALO) United States $5.220B 17.59
Intra-Cellular Therapies (ITCI) United States $5.158B 0.00
Apellis Pharmaceuticals (APLS) United States $5.153B 0.00
Vaxcyte (PCVX) United States $4.922B 0.00
Alkermes (ALKS) Ireland $4.834B 241.83
ACADIA Pharmaceuticals (ACAD) United States $3.857B 0.00
Insmed (INSM) United States $3.763B 0.00
Ginkgo Bioworks Holdings (DNA) United States $3.715B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.612B 0.00
Amicus Therapeutics (FOLD) United States $3.520B 0.00
Axsome Therapeutics (AXSM) United States $3.468B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.259B 0.00
Krystal Biotech (KRYS) United States $3.223B 0.00
Guardant Health (GH) United States $3.052B 0.00
Denali Therapeutics (DNLI) United States $3.044B 0.00
Blueprint Medicines (BPMC) United States $3.004B 0.00
Cytokinetics (CYTK) United States $2.971B 0.00
Intellia Therapeutics (NTLA) United States $2.866B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.758B 0.00
Prothena (PRTA) Ireland $2.730B 0.00
Immunovant (IMVT) United States $2.664B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.605B 0.00
Akero Therapeutics (AKRO) United States $2.553B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.547B 0.00
Nuvalent (NUVL) United States $2.486B 0.00
Fortrea Holdings (FTRE) United States $2.467B 0.00
Zai Lab (ZLAB) China $2.419B 0.00
Mirati Therapeutics (MRTX) United States $2.403B 0.00
Galapagos (GLPG) Belgium $2.324B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.256B 0.00
Certara (CERT) United States $2.250B 37.05
Zealand Pharma (ZLDPF) Denmark $2.222B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.177B 12.09
Ventyx Biosciences (VTYX) United States $2.027B 0.00
Beam Therapeutics (BEAM) United States $1.882B 0.00
Morphic Holding (MORF) United States $1.758B 0.00
Dynavax Technologies (DVAX) United States $1.757B 18.94
Bavarian Nordic (BVNRY) Denmark $1.731B 10.43
CureVac (CVAC) Germany $1.677B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.643B 0.00
Arcellx (ACLX) United States $1.642B 0.00
Vericel (VCEL) United States $1.620B 0.00
IDEAYA Biosciences (IDYA) United States $1.590B 0.00
NeoGenomics (NEO) United States $1.550B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $1.502B 0.00
SpringWorks Therapeutics (SWTX) United States $1.484B 0.00
Arcus Biosciences (RCUS) United States $1.469B 0.00
AbCellera Biologics (ABCL) Canada $1.447B 0.00
Myriad Genetics (MYGN) United States $1.360B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.326B 0.00
Structure Therapeutics (GPCR) United States $1.301B 0.00
Viking Therapeutics (VKTX) United States $1.288B 0.00
Vir Biotechnology (VIR) United States $1.255B 0.00
Arvinas (ARVN) United States $1.215B 0.00
Iovance Biotherapeutics (IOVA) United States $1.207B 0.00
89BIO (ETNB) United States $1.203B 0.00
Celldex Therapeutics (CLDX) United States $1.203B 0.00
Merus (MRUS) Netherlands $1.194B 0.00
ANI Pharmaceuticals (ANIP) United States $1.187B 19.00
Mirum Pharmaceuticals (MIRM) United States $1.177B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.168B 31.40
Twist Bioscience (TWST) United States $1.167B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.164B 0.00
Biohaven (BHVN) United States $1.157B 0.00
Revance Therapeutics (RVNC) United States $1.144B 0.00
Northwest Biotherapeutics (NWBO) United States $1.130B 0.00
Geron (GERN) United States $1.125B 0.00
Disc Medicine (IRON) United States $1.119B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.109B 0.00
MannKind (MNKD) United States $1.090B 0.00
Prime Medicine (PRME) United States $1.078B 0.00
Apogee Therapeutics (APGE) United States $1.058B 0.00
Tango Therapeutics (TNGX) United States $1.050B 0.00
Ligand Pharmaceuticals (LGND) United States $1.025B 22.72
Deciphera Pharmaceuticals (DCPH) United States $1.015B 0.00
Replimune (REPL) United States $0.990B 0.00
Protagonist Therapeutics (PTGX) United States $0.984B 0.00
ACELYRIN, INC (SLRN) United States $0.976B 0.00
Keros Therapeutics (KROS) United States $0.974B 0.00
Kymera Therapeutics (KYMR) United States $0.970B 0.00
Pharming Group (PHGUF) Netherlands $0.913B 0.00
Pliant Therapeutics (PLRX) United States $0.898B 0.00
Immatics (IMTX) Germany $0.898B 0.00
MiMedx (MDXG) United States $0.880B 0.00
Cytek Biosciences (CTKB) United States $0.870B 0.00
Belite Bio (BLTE) United States $0.858B 0.00
Cogent Biosciences (COGT) United States $0.856B 0.00
Inhibrx (INBX) United States $0.851B 0.00
Pharming Group (PHAR) Netherlands $0.847B 0.00
ADMA Biologics Inc (ADMA) United States $0.789B 0.00
PureTech Health (PRTC) United States $0.778B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.778B 0.00
Sana Biotechnology (SANA) United States $0.754B 0.00
ImmunityBio (IBRX) United States $0.753B 0.00
REGENXBIO (RGNX) United States $0.752B 0.00
POINT Biopharma Global (PNT) United States $0.742B 8.07
Adaptive Biotechnologies (ADPT) United States $0.733B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.725B 14.34
Ambrx Biopharma (AMAM) United States $0.702B 0.00
Viridian Therapeutics (VRDN) United States $0.679B 0.00
Novavax (NVAX) United States $0.673B 0.00
Genelux (GNLX) United States $0.663B 0.00
Kura Oncology (KURA) United States $0.658B 0.00
Sinovac Biotech (SVA) China $0.644B 0.00
Vera Therapeutics (VERA) United States $0.644B 0.00
Editas Medicine (EDIT) United States $0.641B 0.00
Cabaletta Bio (CABA) United States $0.630B 0.00
Pharma Mar (PHMMF) Spain $0.621B 0.00
Tyra Biosciences (TYRA) United States $0.612B 0.00
Allogene Therapeutics (ALLO) United States $0.612B 0.00
Avid Bioservices (CDMO) United States $0.606B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.604B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.604B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.593B 0.00
Rapt Therapeutics (RAPT) United States $0.592B 0.00
Travere Therapeutics (TVTX) United States $0.589B 0.00
Alector (ALEC) United States $0.577B 0.00
Anavex Life Sciences (AVXL) United States $0.565B 0.00
Tarsus Pharmaceuticals (TARS) United States $0.553B 0.00
WAVE Life Sciences (WVE) Singapore $0.538B 0.00
Biomea Fusion (BMEA) United States $0.521B 0.00
Olema Pharmaceuticals (OLMA) United States $0.516B 0.00
Repare Therapeutics (RPTX) Canada $0.513B 0.00
HilleVax (HLVX) United States $0.511B 0.00
Entrada Therapeutics (TRDA) United States $0.479B 0.00
Avidity Biosciences (RNA) United States $0.478B 0.00
23andMe Holding (ME) United States $0.472B 0.00
Caribou Biosciences (CRBU) United States $0.449B 0.00
Agenus (AGEN) United States $0.448B 0.00
AnaptysBio (ANAB) United States $0.448B 0.00
Castle Biosciences (CSTL) United States $0.443B 0.00
Janux Therapeutics (JANX) United States $0.443B 0.00
Mineralys Therapeutics (MLYS) United States $0.439B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.438B 0.00
Zymeworks (ZYME) United States $0.434B 2.29
Nurix Therapeutics (NRIX) United States $0.427B 0.00
Oric Pharmaceuticals (ORIC) United States $0.426B 0.00
IGM Biosciences (IGMS) United States $0.425B 0.00
Coherus BioSciences (CHRS) United States $0.421B 0.00
Oculis Holding AG (OCS) Switzerland $0.417B 0.00
Icosavax (ICVX) United States $0.413B 0.00
Liquidia Technologies (LQDA) United States $0.413B 0.00
ITeos Therapeutics (ITOS) United States $0.409B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.406B 0.00
Cullinan Oncology (CGEM) United States $0.406B 0.00
Nautilus Biotechnology (NAUT) United States $0.399B 0.00
Edgewise Therapeutics (EWTX) United States $0.380B 0.00
Amarin (AMRN) Ireland $0.374B 0.00
Aerovate Therapeutics (AVTE) United States $0.369B 0.00
Urogen Pharma (URGN) United States $0.368B 0.00
Precigen (PGEN) United States $0.358B 0.00
Scholar Rock Holding (SRRK) United States $0.358B 0.00
Aura Biosciences (AURA) United States $0.353B 0.00
Erasca (ERAS) United States $0.340B 0.00
UniQure (QURE) Netherlands $0.338B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.336B 0.00
Seres Therapeutics (MCRB) United States $0.335B 0.00
Voyager Therapeutics (VYGR) United States $0.334B 3.35
Arcutis Biotherapeutics (ARQT) United States $0.332B 0.00
Apollomics (APLM) Taiwan $0.326B 0.00
Bluebird Bio (BLUE) United States $0.325B 0.00
Arbutus Biopharma (ABUS) United States $0.323B 0.00
MaxCyte (MXCT) United States $0.322B 0.00
Terns Pharmaceuticals (TERN) United States $0.316B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.307B 0.00
AN2 Therapeutics (ANTX) United States $0.300B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.298B 0.00
Humacyte (HUMA) United States $0.298B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.296B 0.00
MeiraGTx Holdings (MGTX) United States $0.295B 0.00
Nuvation Bio (NUVB) United States $0.291B 0.00
Inozyme Pharma (INZY) United States $0.284B 0.00
DBV Technologies S.A (DBVT) France $0.277B 0.00
Zura Bio (ZURA) United States $0.276B 0.00
Anika Therapeutics (ANIK) United States $0.268B 0.00
Atea Pharmaceuticals (AVIR) United States $0.267B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.262B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.259B 16.70
Fulcrum Therapeutics (FULC) United States $0.258B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.258B 0.00
Ovid Therapeutics (OVID) United States $0.257B 0.00
ScPharmaceuticals (SCPH) United States $0.252B 0.00
Compass Therapeutics (CMPX) United States $0.250B 0.00
AC Immune (ACIU) Switzerland $0.248B 0.00
Third Harmonic Bio (THRD) United States $0.247B 0.00
Verastem (VSTM) United States $0.245B 0.00
Lifecore Biomedical (LFCR) United States $0.244B 0.00
Nuvectis Pharma (NVCT) United States $0.240B 0.00
Scilex Holding (SCLX) United States $0.236B 0.00
Kamada (KMDA) Israel $0.232B 17.83
Y-mAbs Therapeutics (YMAB) United States $0.228B 0.00
Renovaro Biosciences (RENB) United States $0.227B 0.00
Inventiva S.A (IVA) France $0.227B 0.00
Immuneering (IMRX) United States $0.224B 0.00
Gracell Biotechnologies (GRCL) China $0.221B 0.00
Celcuity (CELC) United States $0.220B 0.00
Akoya Biosciences (AKYA) United States $0.216B 0.00
Innate Pharma S.A (IPHA) France $0.215B 0.00
Fate Therapeutics (FATE) United States $0.208B 0.00
Sagimet Biosciences (SGMT) United States $0.208B 0.00
ALX Oncology Holdings (ALXO) United States $0.207B 0.00
Mesoblast (MESO) Australia $0.202B 0.00
CorMedix Inc (CRMD) United States $0.201B 0.00
Vigil Neuroscience (VIGL) United States $0.201B 0.00
Sutro Biopharma (STRO) United States $0.200B 0.00
TELA Bio (TELA) United States $0.198B 0.00
Astria Therapeutics (ATXS) United States $0.196B 0.00
Ikena Oncology (IKNA) United States $0.193B 0.00
Tenaya Therapeutics (TNYA) United States $0.192B 0.00
Allakos (ALLK) United States $0.189B 0.00
Praxis Precision Medicines (PRAX) United States $0.185B 0.00
Stoke Therapeutics (STOK) United States $0.185B 0.00
Rallybio (RLYB) United States $0.184B 0.00
Atara Biotherapeutics (ATRA) United States $0.181B 0.00
Gossamer Bio (GOSS) United States $0.180B 0.00
XOMA (XOMA) United States $0.180B 0.00
Invivyd (IVVD) United States $0.179B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.175B 0.00
Vaxxinity (VAXX) United States $0.175B 0.00
Prima BioMed (IMMP) Australia $0.174B 0.00
Omega Therapeutics (OMGA) United States $0.173B 0.00
X4 Pharmaceuticals (XFOR) United States $0.171B 0.00
Molecular Partners AG (MOLN) Switzerland $0.171B 0.00
Applied Therapeutics (APLT) United States $0.170B 0.00
Adverum Biotechnologies (ADVM) United States $0.170B 0.00
Emergent Biosolutions (EBS) United States $0.169B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.169B 0.00
GENFIT S.A (GNFT) France $0.167B 0.00
Poseida Therapeutics (PSTX) United States $0.165B 0.00
Selecta Biosciences (SELB) United States $0.163B 0.00
PDS Biotechnology (PDSB) United States $0.161B 0.00
LianBio (LIAN) United States $0.161B 0.00
2seventy Bio (TSVT) United States $0.159B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.158B 0.00
Oncolytics Biotech (ONCY) Canada $0.156B 0.00
Mersana Therapeutics (MRSN) United States $0.153B 0.00
Seer (SEER) United States $0.146B 0.00
Vor Biopharma (VOR) $0.146B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.143B 0.00
InflaRx (IFRX) Germany $0.139B 0.00
Rani Therapeutics Holdings (RANI) United States $0.138B 0.00
Ocean Biomedical (OCEA) United States $0.138B 0.00
Graphite Bio (GRPH) United States $0.138B 0.00
Puma Biotechnology (PBYI) United States $0.137B 0.00
Sangamo Therapeutics (SGMO) United States $0.137B 0.00
Absci (ABSI) United States $0.136B 0.00
Trevi Therapeutics (TRVI) United States $0.135B 0.00
Adocia (ADOCY) France $0.135B 0.00
Design Therapeutics (DSGN) United States $0.134B 0.00
XBiotech (XBIT) United States $0.133B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.129B 0.00
Annexon (ANNX) United States $0.128B 0.00
TScan Therapeutics (TCRX) United States $0.127B 0.00
INmune Bio (INMB) United States $0.124B 0.00
Decibel Therapeutics (DBTX) United States $0.123B 0.00
Aadi Bioscience (AADI) United States $0.122B 0.00
Theseus Pharmaceuticals (THRX) United States $0.122B 0.00
PepGen (PEPG) United States $0.122B 0.00
Eton Pharmaceuticals (ETON) United States $0.119B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.119B 0.00
Gritstone Bio (GRTS) United States $0.116B 0.00
Greenwich LifeSciences (GLSI) United States $0.113B 0.00
Codexis (CDXS) United States $0.109B 0.00
DiaMedica Therapeutics (DMAC) United States $0.106B 0.00
Genenta Science S.p.A (GNTA) Italy $0.106B 0.00
Inovio Pharmaceuticals (INO) United States $0.106B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.104B 0.00
Bionano Genomics (BNGO) United States $0.103B 0.00
Cue Biopharma (CUE) United States $0.103B 0.00
ChromaDex (CDXC) United States $0.103B 0.00
Ocugen (OCGN) United States $0.103B 0.00
MediciNova (MNOV) United States $0.103B 0.00
Kodiak Sciences (KOD) United States $0.102B 0.00
C4 Therapeutics (CCCC) United States $0.100B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.100B 0.00
Opthea (OPT) Australia $0.099B 0.00
Graf Acquisition IV (GFOR) United States $0.099B 0.00
I-Mab (IMAB) China $0.099B 0.00
PhenomeX (CELL) United States $0.098B 0.00
Spruce Biosciences (SPRB) United States $0.097B 0.00
IO Biotech (IOBT) Denmark $0.097B 0.00
Cellectis S.A (CLLS) France $0.096B 0.00
Abeona Therapeutics (ABEO) United States $0.094B 0.00
Cidara Therapeutics (CDTX) United States $0.092B 0.00
ATyr Pharma (LIFE) United States $0.092B 0.00
Cara Therapeutics (CARA) United States $0.090B 0.00
Gamida Cell (GMDA) United States $0.090B 0.00
Annovis Bio (ANVS) United States $0.089B 0.00
Immunome (IMNM) United States $0.088B 0.00
NGM Biopharmaceuticals (NGM) United States $0.087B 0.00
BRIACELL THERAP (BCTX) Canada $0.087B 0.00
Jasper Therapeutics (JSPR) United States $0.086B 0.00
BioAtla (BCAB) United States $0.086B 0.00
CytomX Therapeutics (CTMX) United States $0.085B 0.00
BioXcel Therapeutics (BTAI) United States $0.085B 0.00
Compugen (CGEN) Israel $0.085B 0.00
Data Knights Acquisition (DKDCA) United Kingdom $0.085B 0.00
Beyond Air (XAIR) United States $0.084B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.084B 0.00
Kezar Life Sciences (KZR) United States $0.083B 0.00
Syros Pharmaceuticals (SYRS) United States $0.082B 0.00
Turnstone Biologics (TSBX) United States $0.082B 0.00
Genetron Holdings (GTH) China $0.082B 0.00
Ocuphire Pharma (OCUP) United States $0.081B 4.61
Nkarta (NKTX) United States $0.079B 0.00
Werewolf Therapeutics (HOWL) United States $0.079B 0.00
Kronos Bio (KRON) United States $0.076B 0.00
Athira Pharma (ATHA) United States $0.075B 0.00
Evelo Biosciences (EVLO) United States $0.075B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.075B 0.00
HCW Biologics (HCWB) United States $0.074B 0.00
Cardiff Oncology (CRDF) United States $0.072B 0.00
Affimed (AFMD) Germany $0.069B 0.00
Enzo Biochem (ENZ) United States $0.068B 0.00
AVROBIO (AVRO) United States $0.068B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.067B 0.00
Kinnate Biopharma (KNTE) United States $0.066B 0.00
Sorrento Therapeutics (SRNEQ) United States $0.066B 0.00
Elicio Therapeutics (ELTX) United States $0.066B 0.00
Prenetics Global (PRE) Cayman Islands $0.065B 1.54
Vaccitech (VACC) United Kingdom $0.065B 0.00
Shattuck Labs (STTK) United States $0.064B 0.00
Spero Therapeutics (SPRO) United States $0.064B 0.00
G1 Therapeutics (GTHX) United States $0.064B 0.00
Adicet Bio (ACET) United States $0.063B 0.00
Xilio Therapeutics (XLO) United States $0.061B 0.00
Eyenovia (EYEN) United States $0.061B 0.00
Immunic (IMUX) United States $0.061B 0.00
Clene (CLNN) United States $0.059B 0.00
Dyadic (DYAI) United States $0.058B 0.00
Alpha Teknova (TKNO) United States $0.057B 0.00
Adagene (ADAG) China $0.057B 0.00
Immix Biopharma (IMMX) United States $0.056B 0.00
Solid Biosciences (SLDB) United States $0.055B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.055B 0.00
Oncobiologics (OTLK) United States $0.054B 0.00
Instil Bio (TIL) United States $0.054B 0.00
Clearside Biomedical (CLSD) United States $0.053B 0.00
Curis (CRIS) United States $0.053B 0.00
Rezolute (RZLT) United States $0.052B 0.00
Theratechnologies (THTX) Canada $0.052B 0.00
Dianthus Therapeutics (DNTH) United States $0.051B 0.00
OKYO Pharma (OKYO) $0.051B 0.00
HOOKIPA Pharma (HOOK) United States $0.050B 0.00
Intensity Therapeutics (INTS) United States $0.050B 0.00
VistaGen Therapeutics (VTGN) United States $0.049B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.048B 0.00
Science 37 Holdings (SNCE) United States $0.048B 0.00
Longeveron (LGVN) United States $0.046B 0.00
VTv Therapeutics (VTVT) United States $0.046B 0.00
MiNK Therapeutics (INKT) United States $0.045B 0.00
Celularity (CELU) United States $0.044B 0.00
Precision BioSciences (DTIL) United States $0.044B 0.00
Galena Biopharma (SLS) United States $0.043B 0.00
Portage Biotech (PRTG) $0.043B 0.00
Quince Therapeutics (QNCX) United States $0.042B 0.00
Fortress Biotech (FBIO) United States $0.040B 0.00
Dare Bioscience (DARE) United States $0.040B 0.00
Cognition Therapeutics (CGTX) United States $0.040B 0.00
Connect Biopharma Holdings (CNTB) United States $0.040B 0.00
Coya Therapeutics (COYA) United States $0.040B 0.00
Lantern Pharma (LTRN) United States $0.040B 0.00
Bolt Biotherapeutics (BOLT) United States $0.039B 0.00
IN8bio (INAB) United States $0.039B 0.00
Mainz Biomed (MYNZ) Germany $0.038B 0.00
NextCure (NXTC) United States $0.038B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.037B 0.00
Passage Bio (PASG) United States $0.037B 0.00
Miromatrix Medical (MIRO) United States $0.037B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.037B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.036B 0.00
UNITY Biotechnology (UBX) United States $0.036B 0.00
Telesis Bio (TBIO) United States $0.036B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
Checkpoint Therapeutics (CKPT) United States $0.034B 0.00
Aligos Therapeutics (ALGS) United States $0.033B 0.00
Candel Therapeutics (CADL) United States $0.033B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.033B 0.00
NuCana (NCNA) United Kingdom $0.032B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.032B 0.00
Rain Oncology (RAIN) United States $0.031B 0.00
BeyondSpring (BYSI) United States $0.031B 0.00
Axcella Health (AXLA) United States $0.031B 0.00
Neoleukin Therapeutics (NLTX) United States $0.030B 0.00
Cyclo Therapeutics (CYTH) United States $0.030B 0.00
Elevation Oncology (ELEV) United States $0.030B 0.00
Biora Therapeutics (BIOR) United States $0.030B 0.00
SAB Biotherapeutics (SABS) United States $0.029B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.028B 0.00
Forte Biosciences (FBRX) United States $0.028B 0.00
TradeUP Acquisition (UPTD) United States $0.027B 0.00
Equillium (EQ) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Liminal BioSciences (LMNL) Canada $0.026B 0.00
KALA BIO (KALA) United States $0.026B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Pluri (PLUR) Israel $0.024B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.024B 0.00
Lumos Pharma (LUMO) United States $0.023B 0.00
Sensei Biotherapeutics (SNSE) United States $0.023B 0.00
GENPREX (GNPX) United States $0.023B 0.00
Elutia (ELUT) United States $0.023B 0.00
Synlogic (SYBX) United States $0.023B 0.00
Kineta (KA) United States $0.022B 0.00
Aptose Biosciences (APTO) Canada $0.022B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.022B 0.00
Alzamend Neuro (ALZN) United States $0.021B 0.00
YS Biopharma (YS) China $0.021B 1.03
Evaxion Biotech (EVAX) Denmark $0.021B 0.00
Medicenna Therapeutics (MDNA) Canada $0.021B 0.00
Seelos Therapeutics (SEEL) United States $0.021B 0.00
Entera Bio (ENTX) Israel $0.020B 0.00
Senti Biosciences (SNTI) United States $0.020B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
Acorda Therapeutics (ACOR) United States $0.019B 0.00
Cocrystal Pharma (COCP) United States $0.019B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.019B 0.00
Purple Biotech (PPBT) Israel $0.019B 0.00
Mustang Bio (MBIO) United States $0.019B 0.00
Catalyst Biosciences (CBIO) United States $0.019B 0.00
Virios Therapeutics (VIRI) United States $0.018B 0.00
Edesa Biotech (EDSA) Canada $0.018B 0.00
Orgenesis (ORGS) United States $0.018B 0.00
AquaBounty Technologies (AQB) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Freeline Therapeutics Holdings (FRLN) United Kingdom $0.017B 0.00
PHAXIAM Therapeutics S.A (PHXM) France $0.017B 0.00
Lisata Therapeutics (LSTA) United States $0.017B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Vascular Biogenics (VBLT) Israel $0.016B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.016B 0.00
Galecto (GLTO) Denmark $0.016B 0.00
Aprea Therapeutics (APRE) United States $0.016B 0.00
VBI Vaccines (VBIV) United States $0.015B 0.00
CalciMedica (CALC) United States $0.015B 0.00
ZIVO Bioscience (ZIVO) United States $0.015B 0.00
RenovoRx (RNXT) United States $0.014B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.014B 0.00
Frequency Therapeutics (FREQ) United States $0.014B 0.00
Senesco Technologies (ELOX) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.013B 0.00
Biofrontera (BFRI) United States $0.013B 0.00
Atreca (BCEL) United States $0.013B 0.00
AEterna Zentaris (AEZS) Canada $0.012B 0.00
Landos Biopharma (LABP) United States $0.012B 0.00
TFF Pharmaceuticals (TFFP) United States $0.012B 0.00
Moleculin Biotech (MBRX) United States $0.012B 0.00
Organovo Holdings (ONVO) United States $0.012B 0.00
Pasithea Therapeutics (KTTA) United States $0.012B 0.00
Cingulate (CING) United States $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Avalon GloboCare (ALBT) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.011B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
ARAVIVE, INC (ARAV) United States $0.010B 0.00
Chemomab Therapeutics (CMMB) Israel $0.010B 0.00
Talis Biomedical (TLIS) United States $0.010B 0.00
GT Biopharma (GTBP) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.010B 0.00
Cadrenal Therapeutics (CVKD) United States $0.009B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.009B 0.00
Trevena (TRVN) United States $0.009B 0.00
Blue Water Biotech (BWV) United States $0.009B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
BioCardia (BCDA) United States $0.009B 0.00
Bionomics (BNOX) Australia $0.009B 0.00
Sunshine Biopharma (SBFM) Canada $0.009B 0.00
Cohbar (CWBR) United States $0.008B 0.00
Monopar Therapeutics (MNPR) United States $0.008B 0.00
Comera Life Sciences Holdings (CMRA) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Atrinsic (PTIX) United States $0.008B 0.00
Galera Therapeutics (GRTX) United States $0.008B 0.00
Biorestorative Therapies (BRTX) United States $0.008B 0.00
Kintara Therapeutics (KTRA) United States $0.008B 0.00
Lexaria Bioscience (LEXX) Canada $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.007B 0.00
Aileron Therapeutics (ALRN) United States $0.007B 0.00
Applied Molecular Transport (AMTI) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
TRACON Pharmaceuticals (TCON) United States $0.007B 0.00
Athersys (ATHX) United States $0.007B 0.00
Bright Minds Biosciences (DRUG) United States $0.007B 0.00
Exicure (XCUR) United States $0.006B 0.45
CervoMed (CRVO) United States $0.006B 0.00
Aytu BioPharma (AYTU) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.005B 0.00
NexImmune (NEXI) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Benitec Biopharma (BNTC) United States $0.005B 0.00
Bellerophon Therapeutics (BLPH) United States $0.005B 0.00
Windtree Therapeutics (WINT) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
Femasys (FEMY) United States $0.005B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Biophytis SA (BPTS) France $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Hillstream BioPharma (HILS) United States $0.004B 0.00
Aptevo Therapeutics (APVO) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.04
Synaptogenix (SNPX) United States $0.004B 0.00
Panbela Therapeutics (PBLA) United States $0.004B 0.00
ABVC BioPharma (ABVC) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
Aceragen (ACGN) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.24
ThermoGenesis Holdings (THMO) United States $0.003B 0.00
First Wave BioPharma (FWBI) United States $0.002B 0.07
Bone Biologics (BBLG) United States $0.002B 0.00
Invo BioScience (INVO) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
MorphoSys AG (MOR) Germany $0.000B 17.44
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
ARCA Biopharma (ABIO) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
GH Research (GHRS) Ireland $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00